See also this year's filing and all EDGAR filings for this company.
PDF Report 0001797768_2023_Kinnate_Biopharma_Inc.pdf
Logs
Graph
Absolute values for 0001797768, Kinnate Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 230,837,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,071,000 |
| 3 | remainder_Assets | 44,918,000 |
| 4 | LiabilitiesCurrent | 17,167,000 |
| 5 | LiabilitiesNoncurrent | 3,191,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,371,000 |
| 9 | ResearchAndDevelopmentExpense | 88,150,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,250,000 |
| 13 | remainder_ComprehensiveNetIncome | -886,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 278,826,000 |
| 1 | Liabilities | 20,358,000 |
| 2 | Expenses | 118,521,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 258,468,000 |
| 5 | NetIncome | -116,271,000 |
| 6 | ComprehensiveNetIncome | -116,714,000 |
| 7 | BaseVar | 210,420,500 |
| 8 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
